title: [Vitamin B12 deficiency: what's new?].
abstract: Vitamin B12 screening is only recommended among symptomatic patients or in those with risk factors. The main cause of vitamin B12 deficiency is the food cobalamin malabsorption syndrom. Holotranscobalamin is a more reliable marker than cyanocobalamin to confirm vitamin B12 deficiency, but it has not been validated yet in complex situations. An autoimmune gastritis must be excluded in the absence of risk factors but in the presence of a probable deficiency. Oral substitution treatment is effective but requires excellent therapeutic compliance and close follow-up to monitor the response to treatment. It has not yet been studied among patients suffering from severe symptoms, inflammatory bowel disease and ileal resection.
authors.affiliation: Service de médecine de premier recours, Département de médecine communautaire, de premier recours et des urgences, HUG, 1211 Genève. olivia.braillard@hcuge.ch
authors.forename: O
authors.initials: O
authors.lastname: Braillard
authors.forename: A
authors.initials: A
authors.lastname: Casini
authors.forename: K
authors.initials: K
authors.lastname: Samii
authors.forename: P
authors.initials: P
authors.lastname: Rufenacht
authors.forename: Perron N
authors.initials: PN
authors.lastname: Junod
mesh_terms: D000465:Algorithms; D006801:Humans; D014806:Vitamin B 12 Deficiency / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*